ArticlePloS one2015

Comparison of treatment safety and patient survival in elderly versus nonelderly patients with advanced hepatocellular carcinoma receiving sorafenib combined with transarterial chemoembolization: a propensity score matching study.

Hao Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.